Giuseppe S. Alvaro
Fondateur chez Autifony Therapeutics Ltd.
Profil
Giuseppe S.
Alvaro is the founder and the Chief Research Officer at Autifony Therapeutics Ltd., a company founded in 2011.
He previously worked as the Director & Chemistry Leader at GSK Plc.
Dr. Alvaro holds a doctorate degree from Alma Mater Studiorum - Università di Bologna.
Postes actifs de Giuseppe S. Alvaro
| Sociétés | Poste | Début |
|---|---|---|
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Fondateur | 24/08/2011 |
Anciens postes connus de Giuseppe S. Alvaro
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Directeur/Membre du Conseil | - |
Formation de Giuseppe S. Alvaro
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
